ELISA detection of SARS-CoV-2 antibodies in saliva.
Ontology highlight
ABSTRACT: To facilitate containment of the COVID-19 pandemic currently active in the United States and across the world, options for easy, non-invasive antibody testing are required. Here we have adapted a commercially available, serum-based enzyme-linked immunosorbent assay (ELISA) for use with saliva samples, achieving 84.2% sensitivity and 100% specificity in a set of 149 clinical samples. This strategy will enable widespread, affordable testing for patients who experienced this disease, whilst minimizing exposure risk for healthcare workers.
SUBMITTER: MacMullan MA
PROVIDER: S-EPMC7705674 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA